BEN YIMING ZHANG MD NPI 1366738098

NPI Information

  • NPI: 1366738098
  • Provider Name: BEN YIMING ZHANG, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 675 E NICOLLET BLVD STE 100
    BURNSVILLE, MN
    ZIP 55337
  • Phone: (952) 892-7190

Map and Directions

Get Directions

NPI Details

Ben Yiming Zhang, MD is a hematology and oncology internal medicine in Burnsville, MN with 15 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Ben Yiming Zhang, MD NPI is 1366738098. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Graduation Year:2011

The provider's business location address is:

675 E NICOLLET BLVD STE 100
BURNSVILLE, MN
ZIP 55337-749
Phone: (952) 892-7190
Fax: (952) 892-7956

The NPI 1366738098 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Protein measurement, serum (HCPCS:84165)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Unclassified drugs (HCPCS:J3490)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Folic acid level, serum (HCPCS:82746)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Urinalysis, manual test (HCPCS:81002)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 6/21/2011 and was last updated on 2/21/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology55527MINNESOTAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
11366738098MEDICAIDMINNESOTA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.